ArticleBMC infectious diseases2026

Sustained regression of a tislelizumab-reactivated tuberculous focus after short-course therapy: a case report.

Xiao-Jun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.